Indeed, the finding that deletion or overexpression of PBP1, respectively reduces or enhances TDP-43 toxicity led to the discovery that PBP1′s human homolog, ATXN2, is associated with ALS risk. Here, ATXN2 is linked to amyotrophic lateral sclerosis.